Yahoo
TSXV - Free Realtime Quote CAD

BioSyent Inc. (RX.V)

17.87 -0.03 (-0.17%)
As of 9:30:00 AM EST. Market Open.
View in AlphaSpace Currency in CAD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
55,674.67 43,051.98 35,030.90 31,590.30 27,925.19
Cost of Revenue
-14,823.35 -10,088.96 -7,174.82 -5,992.36 -5,067.30
Gross Profit
40,851.33 32,963.03 27,856.07 25,597.94 22,857.88
Selling, General and Administrative Expenses
-24,780.40 -19,793.65 -17,645.26 -17,266.83 -15,231.58
Research and Development Expenses
-203.73 -341.05 -171.37 -83.27 -121.03
Depreciation, Amortization and Depletion
-1,966.81 -852.49 -589.95 -455.34 -451
Provision Expense/Write-Back
-98.71 -98.71 -136.49 -140.32 -49.97
Other Income/Expense, Operating
-563.97 -563.97 -248.68 -117.93 -97.47
Operating Income/Expenses
-27,511.19 -21,649.87 -18,791.75 -18,063.69 -15,951.04
Total Operating Profit/Loss
13,340.14 11,313.15 9,064.32 7,534.25 6,906.84
Total Net Finance Income/Expense
573.75 759.75 1,029.43 1,062.71 448.65
Net Investment Income
-93.02 -42.89 118.76 -63.11 75.16
Irregular Income/Expenses
-437.63 0 -430.02 0 --
Other Income/Expense, Non-Operating
-- -- -- -- 0
Non-Operating Income/Expenses, Total
43.10 716.86 718.18 999.60 523.81
Pretax Income
13,383.24 12,030.01 9,782.50 8,533.85 7,430.65
Provision for Income Tax
-3,514.86 -3,017.78 -2,512.39 -2,073.73 -1,972.31
Net Income from Continuing Operations
9,868.38 9,012.23 7,270.10 6,460.13 5,458.35
Net Income after Extraordinary Items and Discontinued Operations
9,868.38 9,012.23 7,270.10 6,460.13 5,458.35
Net Income after Non-Controlling/Minority Interests
9,868.38 9,012.23 7,270.10 6,460.13 5,458.35
Net Income Available to Common Stockholders
9,868.38 9,012.23 7,270.10 6,460.13 5,458.35
Diluted Net Income Available to Common Stockholders
9,868.38 9,012.23 7,270.10 6,460.13 5,458.35
Common Dividend per Share
0.04 -- -- -- --
Basic EPS
0.87 0.80 0.63 0.54 0.44
Diluted EPS
0.85 0.78 0.62 0.53 0.43
Basic Weighted Average Shares Outstanding
11,313.29 11,261.60 11,586.77 11,949.90 12,303.12
Diluted Weighted Average Shares Outstanding
11,556.61 11,506.61 11,807.88 12,170.41 12,540.64
Income Statement, Supplemental
EBIT
12,809.49 11,270.27 8,753.06 7,471.14 6,982
EBITDA
14,776.30 12,122.76 9,343.01 7,926.48 7,433
12/31/2022 - 5/8/1996

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: